Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. RSLS stock has plunged more than 90% over the past month and has plummeted more than 99% over the past year. Even with the stock worth less than 15 cents per share, there is little reason for Join Stocktwits for free stock discussions, prices, and market sentiment with millions of investors and traders. Stocktwits is the largest social network for finance. Join Stocktwits for free stock discussions, prices, and market sentiment with millions of investors and traders. Stocktwits is the largest social network for finance. ReShape Lifesciences Inc. operates as a medical device company, which focuses on technology to treat obesity and metabolic diseases. It operates through the following segments: Lap-Band, ReShape Vest and ReShape vBloc. The company was founded on December 2002 and is headquartered in San Clemente, CA.
Find the latest RESHAPE LIFESCIENCES INC (RSLS) stock quote, history, news and other vital information to help you with your stock trading and investing.
Learn about RSLS with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on RSLS. Social media updates, opinions, and reactions on ReShape Lifesciences Inc - Ordinary Shares (RSLS) aggregated in real time from around the web on NASDAQ.com Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results. Company Name: ReShape LifeSciences Inc., Stock Symbol: RSLS, Industry: Medical - Healthcare, Total Posts: 2490, Last Post: 1/24/2020 3:13:33 PM 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. RSLS: Get the latest Reshape Lifesciences stock price and detailed information including RSLS news, historical charts and realtime prices.
Stock analysis for ReShape Lifesciences Inc (ETRM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
You can watch RSLS and buy and sell other stock and options commission-free on Robinhood. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare ReShape Lifesciences against related stocks people have also bought.
Find out the current valuation for RSLS. Stock Style Large-Cap Value ; Large-Cap Core ; Large-Cap Growth ; Mid-Cap Value
SAN CLEMENTE, CA / ACCESSWIRE / November 11, 2019 / ReShape Lifesciences Inc. (RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced that its Board of Directors has declared a 1-for-120 reverse stock split of the company's common stock, which will be effective for trading purposes upon the stock is 100.0% away from all-time highs of $17098100000: rsls is up 20% since the beginning of the year: rsls is up 29% over the past 12 months: rsls is up 31% over the past 1 month: n/a% of all rsls investors are betting against rsls: num investors short rsls has gone up n/a% versus last month Buyout. Not all delistings are necessarily bad -- a company's stock can be delisted in the event of a buyout or merger. If a company is bought out by another public company, stockholders might Reshape Lifesciences Inc (OTCMKTS:RSLS)'s share price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.58 and traded as low as $0.26. Reshape Lifesciences shares last traded at $0.26, with a volume of 0 shares. The company has a fifty day moving average price of […] Reshape Lifesciences Inc's stock rating is based on fundamental analysis. Don't miss RSLS stock next rating changes RSLS stock forecast Our latest prediction for ReShape Lifesciences, Inc.'s stock price was made on the Jan. 29, 2020 when the stock price was at 8.00$.. In the short term (2weeks), RSLS's stock price should underperform the market by -1.62%.During that period the price should oscillate between -14.60% and +17.88%.
RSLS Stock Predictions. Should I buy or sell RSLS stock? If you are thinking about buying RSLS, make sure you check out the free RSLS stock predictions report provided by MarketClub.They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how RSLS will perform in the near future.
Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Get ReShape Lifesciences Inc (RSLS:OTCQB) real-time stock quotes, news and financial information from CNBC. Real time ReShape Lifesciences Inc. (RSLS) stock price quote, stock graph, news & analysis. Find real-time RSLS - ReShape Lifesciences Inc stock quotes, company profile, news and forecasts from CNN Business. RESHAPE LIFESCIENCES INC by ReShape Lifesciences Inc. RSLS:OTCQB OTCQB Early-stage and developing companies that are current in their reporting and undergo an annual verification and management Reshape Lifesciences Inc. (NASDAQ: RSLS) Monday's news was a positive for ReShape stock, and the spike in trading volume triggered a massive morning run-up in the thinly-traded stock. As of Learn about RSLS with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on RSLS.
ReShape Life Sciences. RSLS 5.26 0.76 (16.89%). NASDAQUpdated Mar 19, 2020 7:58 PM. 24,490. Watchers. Watch. Filter by: Real-Time. 0 New Post. Researching Reshape Lifesciences (OTCMKTS:RSLS) stock? View RSLS's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC